Pharmacodynamics and pharmacokinetics of drugs used in pneumonia
Abstract
The prevalence of infectious diseases of the respiratory system and, first of all, pneumonia among the population, the presence of various etiological factors and conditions for the appearance of diseases, doctors of various specialties - therapists, surgeons, neuropathologists - predetermine the occurrence of this disease. Faced with this pathology. Few or atypical clinical signs characteristic of the modern course of pneumonia complicate the diagnosis and complicate the treatment of the patient. The presence of diseases accompanied by decompensation against the background of an infectious lung lesion worsens the prognosis and increases the risk of death. It is especially important to correctly diagnose infectious lung disease in time and to prescribe adequate antibacterial therapy. Pneumonia is a group of acute infectious diseases of different etiology and pathogenesis, characterized by focal damage of the respiratory parts of the lungs and the presence of alveolar exudation (see picture). Modern classification defines the following types of pneumonia: 1) community-acquired - CP (ambulatory) - acquired outside a medical institution; 2) nosocomial (hospital, in-hospital) - acquired in a medical institution; 3) aspiration; 4) pneumonia in people with severe immune deficiencies - pneumonia caused by congenital immunodeficiency, HIV infection, iatrogenic immunosuppression. This division is based on the difference in the conditions in which the disease occurs and the approaches…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.